These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

210 related items for PubMed ID: 19950917

  • 1. Transplatin-conjugated triplex-forming oligonucleotides form adducts with both strands of DNA.
    Campbell MA, Miller PS.
    Bioconjug Chem; 2009 Dec; 20(12):2222-30. PubMed ID: 19950917
    [Abstract] [Full Text] [Related]

  • 2. Inhibition of transcription by platinated triplex-forming oligonucleotides.
    Graham MK, Miller PS.
    J Biol Inorg Chem; 2012 Dec; 17(8):1197-208. PubMed ID: 22965663
    [Abstract] [Full Text] [Related]

  • 3. Cross-linking to an interrupted polypurine sequence with a platinum-modified triplex-forming oligonucleotide.
    Campbell MA, Miller PS.
    J Biol Inorg Chem; 2009 Aug; 14(6):873-81. PubMed ID: 19350290
    [Abstract] [Full Text] [Related]

  • 4. Improved synthesis of daunomycin conjugates with triplex-forming oligonucleotides. The polypurine tract of HIV-1 as a target.
    Capobianco ML, De Champdoré M, Arcamone F, Garbesi A, Guianvarc'h D, B Arimondo P.
    Bioorg Med Chem; 2005 May 02; 13(9):3209-18. PubMed ID: 15809156
    [Abstract] [Full Text] [Related]

  • 5. Improved bioactivity of G-rich triplex-forming oligonucleotides containing modified guanine bases.
    Rogers FA, Lloyd JA, Tiwari MK.
    Artif DNA PNA XNA; 2014 May 02; 5(1):e27792. PubMed ID: 25483840
    [Abstract] [Full Text] [Related]

  • 6. Intercalator conjugates of pyrimidine locked nucleic acid-modified triplex-forming oligonucleotides: improving DNA binding properties and reaching cellular activities.
    Brunet E, Corgnali M, Perrouault L, Roig V, Asseline U, Sørensen MD, Babu BR, Wengel J, Giovannangeli C.
    Nucleic Acids Res; 2005 May 02; 33(13):4223-34. PubMed ID: 16049028
    [Abstract] [Full Text] [Related]

  • 7. Targeting the human androgen receptor gene with platinated triplex-forming oligonucleotides.
    Graham MK, Brown TR, Miller PS.
    Biochemistry; 2015 Apr 07; 54(13):2270-82. PubMed ID: 25768916
    [Abstract] [Full Text] [Related]

  • 8. Inhibition of T7 RNA polymerase transcription by phosphate and phosphorothioate triplex-forming oligonucleotides targeted to a R.Y site downstream from the promoter.
    Alunni-Fabbroni M, Manfioletti G, Manzini G, Xodo LE.
    Eur J Biochem; 1994 Dec 15; 226(3):831-9. PubMed ID: 7813472
    [Abstract] [Full Text] [Related]

  • 9. Triplex-forming oligonucleotides as potential tools for modulation of gene expression.
    Rogers FA, Lloyd JA, Glazer PM.
    Curr Med Chem Anticancer Agents; 2005 Jul 15; 5(4):319-26. PubMed ID: 16101484
    [Abstract] [Full Text] [Related]

  • 10. A Click Chemistry Approach to Targeted DNA Crosslinking with cis-Platinum(II)-Modified Triplex-Forming Oligonucleotides.
    Hennessy J, McGorman B, Molphy Z, Farrell NP, Singleton D, Brown T, Kellett A.
    Angew Chem Int Ed Engl; 2022 Jan 17; 61(3):e202110455. PubMed ID: 34652881
    [Abstract] [Full Text] [Related]

  • 11. Stable oligonucleotide-directed triplex formation at target sites with CG interruptions: strong sequence-specific recognition by 2',4'-bridged nucleic-acid-containing 2-pyridones under physiological conditions.
    Obika S, Hari Y, Sekiguchi M, Imanishi T.
    Chemistry; 2002 Oct 18; 8(20):4796-802. PubMed ID: 12561120
    [Abstract] [Full Text] [Related]

  • 12. Triplex formation by psoralen-conjugated chimeric oligonucleoside methylphosphonates.
    Cassidy RA, Kondo NS, Miller PS.
    Biochemistry; 2000 Jul 25; 39(29):8683-91. PubMed ID: 10913277
    [Abstract] [Full Text] [Related]

  • 13. Triplex-induced recombination and repair in the pyrimidine motif.
    Kalish JM, Seidman MM, Weeks DL, Glazer PM.
    Nucleic Acids Res; 2005 Jul 25; 33(11):3492-502. PubMed ID: 15961731
    [Abstract] [Full Text] [Related]

  • 14. Targeted cross-linking of the human beta-globin gene in living cells mediated by a triple helix forming oligonucleotide.
    Shahid KA, Majumdar A, Alam R, Liu ST, Kuan JY, Sui X, Cuenoud B, Glazer PM, Miller PS, Seidman MM.
    Biochemistry; 2006 Feb 14; 45(6):1970-8. PubMed ID: 16460044
    [Abstract] [Full Text] [Related]

  • 15. Interstrand cross-linking reaction in triplexes containing a monofunctional transplatin-adduct.
    Colombier C, Lippert B, Leng M.
    Nucleic Acids Res; 1996 Nov 15; 24(22):4519-24. PubMed ID: 8948644
    [Abstract] [Full Text] [Related]

  • 16. Synthesis and evaluation of a triplex-forming oligonucleotide-pyrrolobenzodiazepine conjugate.
    Zhilina ZV, Ziemba AJ, Trent JO, Reed MW, Gorn V, Zhou Q, Duan W, Hurley L, Ebbinghaus SW.
    Bioconjug Chem; 2004 Nov 15; 15(6):1182-92. PubMed ID: 15546183
    [Abstract] [Full Text] [Related]

  • 17. Positively charged oligonucleotides overcome potassium-mediated inhibition of triplex DNA formation.
    Dagle JM, Weeks DL.
    Nucleic Acids Res; 1996 Jun 01; 24(11):2143-9. PubMed ID: 8668547
    [Abstract] [Full Text] [Related]

  • 18. Modulation of psoralen DNA crosslinking kinetics associated with a triplex-forming oligonucleotide.
    Oh DH, Suzara V, Krishnan R.
    Photochem Photobiol; 2008 Jun 01; 84(3):727-33. PubMed ID: 18435621
    [Abstract] [Full Text] [Related]

  • 19. DNA damage produced by 125I-triplex-forming oligonucleotides as a measure of their successful delivery into cell nuclei.
    Panyutin IV, Sedelnikova OA, Bonner WM, Panyutin IG, Neumann RD.
    Ann N Y Acad Sci; 2005 Nov 01; 1058():140-50. PubMed ID: 16394133
    [Abstract] [Full Text] [Related]

  • 20. Targeting bcl-2 by triplex-forming oligonucleotide--a promising carrier for gene-radiotherapy.
    Shen C, Rattat D, Buck A, Mehrke G, Polat B, Ribbert H, Schirrmeister H, Mahren B, Matuschek C, Reske SN.
    Cancer Biother Radiopharm; 2003 Feb 01; 18(1):17-26. PubMed ID: 12667305
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.